info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Case ReportOpen Access

Electrochemotherapy on Bladder - Preliminary Results

Volume 12 - Issue 2

Marcelo Monte Mor Rangel1, Krishna Duro de Oliveira1, Jennifer Ostrand Freytag1, Priscila Gil Quadros1 and Daniela Ota Hisayasu Suzuki*2

  • Author Information Open or Close
    • 1Vet Câncer Clinic, Brazil
    • 2Biomedical engineering institute, Brazil
    • *Corresponding author: Daniela Ota Hisayasu Suzuki, Biomedical engineering institute, Brazil

Received: December 07, 2018;   Published: December 17, 2018

DOI: 10.26717/BJSTR.2018.12.002221

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Electrochemotherapy is a technique that associates electropermabilization with the administration of low permeant or non-membrane permeant drugs to membranes [1-3]. The two main drugs used are bleomycin and cisplatin [4,5]. When bleomycin is used, an interesting selectivity to the neoplastic tissue is observed. This is because bleomycin mainly acts on cells that are dividing [6-8]. Bladder cancer in dogs represent about 2% of all neoplasms and usually when diagnosed are staged T2 or T3.

Introductıon| Case Presentation| Results| Discussion| Conclusion| References|